These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 4396598)
21. [Clinical effectiveness and mechanism of action of thymoptic in glaucoma]. Shmyreva VF; Fridman NV; Makashova NV Vestn Oftalmol; 1982; (3):8-10. PubMed ID: 6126027 [No Abstract] [Full Text] [Related]
22. [Experimental justification of pathogenetically directed glaucoma therapy]. Kryzhanovskiĭ GN; Kashintseva LT; Lipovetskaia EM; Kopp OP Oftalmol Zh; 1980; 35(8):493-7. PubMed ID: 6111059 [No Abstract] [Full Text] [Related]
23. [Application of beta blockers in ophthalmology]. Cvetković D Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():51-3. PubMed ID: 18193811 [TBL] [Abstract][Full Text] [Related]
24. [Drug therapy for glaucoma]. Määttä M; Puska P Duodecim; 2009; 125(15):1657-63. PubMed ID: 19769182 [TBL] [Abstract][Full Text] [Related]
25. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern? Good CB Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832 [No Abstract] [Full Text] [Related]
26. [Medical treatment of normal pressure glaucoma. Role of beta-blockers]. J Fr Ophtalmol; 1993; 16(5):338-43. PubMed ID: 8101196 [No Abstract] [Full Text] [Related]
27. [The effects of the Sanotensin eyedrops]. Csigány A Orv Hetil; 1968 Jul; 109(27):1487-8. PubMed ID: 5719102 [No Abstract] [Full Text] [Related]
31. Local guanethidine drops in the treatment of chronic simple glaucoma. Kulshrestha OP; Sharma PC Indian J Ophthalmol; 1972 Sep; 20(3):123-6. PubMed ID: 4668486 [No Abstract] [Full Text] [Related]
32. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)]. Tugushi OA; Shliapuzhnikova AV; Listopadova NA Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045 [No Abstract] [Full Text] [Related]
33. [Guanethidine in the glucoma therapy]. Merté HJ; Toppel L Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1968; 176(1):30-42. PubMed ID: 5303445 [No Abstract] [Full Text] [Related]
34. [Drug therapy in the treatment of glaucoma]. Thieme H Klin Monbl Augenheilkd; 2006 Sep; 223(9):R73-8; quiz R79-80. PubMed ID: 16986080 [No Abstract] [Full Text] [Related]
35. [Treatment of glaucoma with beta receptor blockers]. Demmler N Fortschr Med; 1980 Jun; 98(23):880-5. PubMed ID: 6106627 [TBL] [Abstract][Full Text] [Related]
36. A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond: the Proctor Lecture. Bito LZ Invest Ophthalmol Vis Sci; 2001 May; 42(6):1126-33. PubMed ID: 11328718 [No Abstract] [Full Text] [Related]
37. Brimonidine--an alpha 2-agonist for glaucoma. Med Lett Drugs Ther; 1997 Jun; 39(1002):54-5. PubMed ID: 9198727 [No Abstract] [Full Text] [Related]
38. Pathogenesis and treatment of endocrine exophthalmos. Haddad HM Int Surg; 1973 Jul; 58(7):482-4. PubMed ID: 4740436 [No Abstract] [Full Text] [Related]